Pre-symptomatic detection of prions by cyclic amplification of protein misfolding

被引:113
作者
Soto, C [1 ]
Anderes, L
Suardi, S
Cardone, F
Castilla, J
Frossard, MJ
Peano, S
Saa, P
Limido, L
Carbonatto, M
Ironside, J
Torres, JM
Pocchiari, M
Tagliavini, F
机构
[1] Univ Texas, Med Branch, Dept Neurol, Galveston, TX 77555 USA
[2] Serono Pharmaceut Res Inst, Geneva, Switzerland
[3] Ist Nazl Neurol Carlo Besta, Milan, Italy
[4] Ist Super Sanita, I-00161 Rome, Italy
[5] Ist Ric Biomed Antoine Marxer, RBM, LCG, Collereto Giacosa, Italy
[6] Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland
[7] Ctr Invest Sanidad Anim, Madrid, Spain
关键词
prion; diagnosis; bovine spongiform; encephalopathy; protein misfolding;
D O I
10.1016/j.febslet.2004.12.035
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transmissible spongiform encephalopathies (TSEs) are neurodegenerative disorders affecting humans and animals. At present, it is not possible to recognize individuals incubating the disease before the clinical symptoms appear. We investigated the effectiveness of the "Protein Misfolding Cyclic Amplification" (PMCA) technology to detect the protease-resistance disease-associated prion protein (PrPres) in pre-symptomatic stages. PMCA allowed detection of PrPres in the brain of pre-symptomatic hamsters, enabling a clear identification of infected animals as early as two weeks after inoculation. Furthermore, PMCA was able to amplify minute quantities of PrPres from a variety of experimental and natural TSEs. Finally, PMCA allowed the demonstration of PrPres in an experimentally infected cow 32 month post-inoculation, that did not show clinical signs and was negative by standard Western blot analysis. Our findings indicate that PMCA may be useful for the development of an ultra-sensitive diagnostic test to minimize the risk of further propagation of TSEs. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:638 / 642
页数:5
相关论文
共 30 条
[11]   Rapid test for the preclinical postmortem diagnosis of BSE in central nervous system tissue [J].
Grassi, J ;
Comoy, E ;
Simon, S ;
Créminon, C ;
Frobert, Y ;
Trapmann, S ;
Schimmel, H ;
Hawkins, SAC ;
Moynagh, J ;
Deslys, JR ;
Wells, GAH .
VETERINARY RECORD, 2001, 149 (19) :577-582
[12]   Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy [J].
Hill, AF ;
Zeidler, M ;
Ironside, J ;
Collinge, J .
LANCET, 1997, 349 (9045) :99-100
[13]   Molecular diagnostics of transmissible spongiform encephalopathies [J].
Ingrosso, L ;
Vetrugno, V ;
Cardone, F ;
Pocchiari, M .
TRENDS IN MOLECULAR MEDICINE, 2002, 8 (06) :273-280
[14]  
KIMBERLIN RH, 1988, CIBA F SYMP, V135, P37
[15]   SPECIES-SPECIFICITY IN THE CELL-FREE CONVERSION OF PRION PROTEIN TO PROTEASE-RESISTANT FORMS - A MODEL FOR THE SCRAPIE SPECIES BARRIER [J].
KOCISKO, DA ;
PRIOLA, SA ;
RAYMOND, GJ ;
CHESEBRO, B ;
LANSBURY, PT ;
CAUGHEY, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) :3923-3927
[16]   In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups [J].
Lucassen, R ;
Nishina, K ;
Supattapone, S .
BIOCHEMISTRY, 2003, 42 (14) :4127-4135
[17]  
Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO
[18]  
2-W
[19]   Prions [J].
Prusiner, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) :13363-13383
[20]   Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding [J].
Saborio, GP ;
Permanne, B ;
Soto, C .
NATURE, 2001, 411 (6839) :810-813